sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_7 ;
    pav:version "1.4" .
  sub:_6 prov:value "Significant expression of Vcam-1 was observed in wild-type mice on day 6 following intranasal challange with OVA, while very faint or no Vcam-1 expression was seen in identically OVA sensitized/ challenged IL12 Knockout mice. Scores of Vcam-1 staining showed a significant less Vcam-1 expression in IL12 KO mice. The supplement of recombinant IL12 (rIL12) to IL12 KO mice significantly increased the expression of Vcam-1. The Vcam-1 expression score in rIL12-treated mice was 1.17, while the score in IL-12 KO mice without rIL-12 treatment was 0.17 (p < 0.05). These results indicate that IL-12 increased the expression of Vcam-1." ;
    prov:wasQuotedFrom pubmed:11160340 .
  sub:_7 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:11160340 ;
    prov:wasDerivedFrom beldoc: , sub:_6 .
}